Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Prashant Jivaji Bhide"'
Publikováno v:
ASSAY and Drug Development Technologies. 21:97-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b1e914dcd7c916aaec8d46709c403c1
https://doi.org/10.1089/adt.2022.091
https://doi.org/10.1089/adt.2022.091
Autor:
Salika Santosh Mapari, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar
Publikováno v:
Tenside Surfactants Detergents. 60:124-139
The present study aimed to enhance the transdermal delivery of lacidipine by niosomal vesicles. Lacidipine niosomes were generated using the ultrasonic method, and Span 60 was used as a nonionic surfactant. Formulations were prepared containing Span
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e5629549c9ffc9d87ab187d55bd1957
https://doi.org/10.1515/tsd-2022-2439
https://doi.org/10.1515/tsd-2022-2439
Autor:
Anjali Ambalal Purohit, Dikshita Ullas Chavan, Shirleen Miriam Marques, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Rupesh Kalidas Shirodkar
Publikováno v:
Tenside Surfactants Detergents. 59:373-382
Despite numerous remarkable developments in clinical therapy, the world remains firmly in the grip of fungal infections. While conventional approaches to antifungal therapy are failing, dermatophytes continue to affect people’s daily lives, especia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e165e0ac05428f7b501b07950082e7c
https://doi.org/10.1515/tsd-2022-2442
https://doi.org/10.1515/tsd-2022-2442
Autor:
Apoorva Ratnakar Barve, Gauri Ramchandra Kapileshwari, Cleona Elizabeth Mary DCruz, Lalit Kumar, Prashant Jivaji Bhide, Anand Avinash Mahajan, Asmita Sunil Arondekar, Rupesh Kalidas Shirodkar
Publikováno v:
Assay and drug development technologies. 20(6)
Ebastine, a histamine H1 antagonist, nonsedating, belonging to BCS class II is used in the treatment of allergic rhinitis and chronic idiopathic urticaria. The current study was intended in augmenting the aqueous solubility and dissolution rate of eb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a539ab6e40b443216ca31507d30580
https://pubmed.ncbi.nlm.nih.gov/36070596
https://pubmed.ncbi.nlm.nih.gov/36070596
Publikováno v:
International Journal of Applied Pharmaceutics. :170-177
Objective: The objective of the present work was to formulate and evaluate a fast-dissolving oral film of lurasidone hydrochlorideused as an atypical antipsychotic for the treatment of schizophrenia capable of providing faster onset of action. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf13077d471966f412dff9cb5269c065
https://doi.org/10.22159/ijap.2021v13i1.39492
https://doi.org/10.22159/ijap.2021v13i1.39492
Publikováno v:
International Journal of Current Pharmaceutical Research. :111-115
Objective: To overcome the limitations of fast dissolving tablets, a novel fast dissolving film of ebastine was formulated for attaining quick onset of action, aiding in the enhancement of bioavailability favorable in severe conditions of allergies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2804623ba391a8a5fb6a51996a352f6
https://doi.org/10.22159/ijcpr.2020v12i5.39782
https://doi.org/10.22159/ijcpr.2020v12i5.39782
Autor:
Rupesh Kalidas Shirodkar, Lalit Kumar, Shirleen Miriam Marques, Dikshita Ullas Chavan, Prashant Jivaji Bhide, Madhusudan Joshi
Publikováno v:
Current drug delivery.
Background: The formulation of spanlastic vesicles of luliconazole can be used to overcome its poor skin permeation and improve its antifungal efficacy. Objective: In this study, we aimed to enhance the dermal delivery of luliconazole, an antifungal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::097866f3306f7935df5910fe3a5e883e
https://pubmed.ncbi.nlm.nih.gov/35578877
https://pubmed.ncbi.nlm.nih.gov/35578877
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 53:s571-s579
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28ac749414da3ddf26cbd81582be7803
https://doi.org/10.5530/ijper.53.4s.152
https://doi.org/10.5530/ijper.53.4s.152
Publikováno v:
Pharmaceutical Chemistry Journal. 53:720-729
Ebastine (EBS) is a second-generation non-sedating antihistamine used for the prevention and treatment of allergic rhinitis and chronic idiopathic urticaria. It is BCS class II drug exhibiting low aqueous solubility and poor oral bioavailability. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::622e9128e1a5cd6c090a776104fadb4b
https://doi.org/10.1007/s11094-019-02069-x
https://doi.org/10.1007/s11094-019-02069-x
SOLUBILITY ENHANCEMENT OF CELECOXIB BY SOLID DISPERSION TECHNIQUE AND INCORPORATION INTO TOPICAL GEL
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :294-300
Objective: The aim of the present investigation was to design gels for the topical delivery of celecoxib and evaluate with an aim to increase its penetration through the skin and thereby its flux. Method: The solubility of celecoxib is shown to be in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::953a808ff11c1ac21006fbeeef628333
https://doi.org/10.22159/ajpcr.2019.v12i2.29784
https://doi.org/10.22159/ajpcr.2019.v12i2.29784